These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15456860)

  • 1. Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells.
    Paredes R; Arriagada G; Cruzat F; Villagra A; Olate J; Zaidi K; van Wijnen A; Lian JB; Stein GS; Stein JL; Montecino M
    Mol Cell Biol; 2004 Oct; 24(20):8847-61. PubMed ID: 15456860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity.
    Sierra J; Villagra A; Paredes R; Cruzat F; Gutierrez S; Javed A; Arriagada G; Olate J; Imschenetzky M; Van Wijnen AJ; Lian JB; Stein GS; Stein JL; Montecino M
    Mol Cell Biol; 2003 May; 23(9):3339-51. PubMed ID: 12697832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Runx2 transcription factor plays a key role in the 1alpha,25-dihydroxy Vitamin D3-dependent upregulation of the rat osteocalcin (OC) gene expression in osteoblastic cells.
    Paredes R; Arriagada G; Cruzat F; Olate J; Van Wijnen A; Lian J; Stein G; Stein J; Montecino M
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):269-71. PubMed ID: 15225783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the 1alpha,25-dihydroxyvitamin D3 receptor at the distal promoter region of the bone-specific osteocalcin gene requires nucleosomal remodelling.
    Paredes R; Gutiérrez J; Gutierrez S; Allison L; Puchi M; Imschenetzky M; van Wijnen A; Lian J; Stein G; Stein J; Montecino M
    Biochem J; 2002 May; 363(Pt 3):667-76. PubMed ID: 11964167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha,25-dihydroxy vitamin D3-enhanced expression of the osteocalcin gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1alpha,25-dihydroxy vitamin D3 receptor-SRC-1 coactivator complex.
    Carvallo L; Henríquez B; Paredes R; Olate J; Onate S; van Wijnen AJ; Lian JB; Stein GS; Stein JL; Montecino M
    J Cell Physiol; 2008 Mar; 214(3):740-9. PubMed ID: 17786964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vitamin D response element in the distal osteocalcin promoter contributes to chromatin organization of the proximal regulatory domain.
    Gutierrez S; Liu J; Javed A; Montecino M; Stein GS; Lian JB; Stein JL
    J Biol Chem; 2004 Oct; 279(42):43581-8. PubMed ID: 15299011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
    Lu X; Farmer P; Rubin J; Nanes MS
    J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
    Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL
    Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression.
    Xiao G; Jiang D; Ge C; Zhao Z; Lai Y; Boules H; Phimphilai M; Yang X; Karsenty G; Franceschi RT
    J Biol Chem; 2005 Sep; 280(35):30689-96. PubMed ID: 16000305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 1alpha,25-dihydroxy Vitamin D3 receptor preferentially recruits the coactivator SRC-1 during up-regulation of the osteocalcin gene.
    Carvallo L; Henriquez B; Olate J; van Wijnen AJ; Lian JB; Stein GS; Onate S; Stein JL; Montecino M
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):420-4. PubMed ID: 17218095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter.
    Drissi H; Pouliot A; Koolloos C; Stein JL; Lian JB; Stein GS; van Wijnen AJ
    Exp Cell Res; 2002 Apr; 274(2):323-33. PubMed ID: 11900492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene.
    Guo B; Aslam F; van Wijnen AJ; Roberts SG; Frenkel B; Green MR; DeLuca H; Lian JB; Stein GS; Stein JL
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):121-6. PubMed ID: 8990171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
    van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
    J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression.
    Gutierrez S; Javed A; Tennant DK; van Rees M; Montecino M; Stein GS; Stein JL; Lian JB
    J Biol Chem; 2002 Jan; 277(2):1316-23. PubMed ID: 11668178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AP-1 and vitamin D receptor (VDR) signaling pathways converge at the rat osteocalcin VDR element: requirement for the internal activating protein-1 site for vitamin D-mediated trans-activation.
    Aslam F; McCabe L; Frenkel B; van Wijnen AJ; Stein GS; Lian JB; Stein JL
    Endocrinology; 1999 Jan; 140(1):63-70. PubMed ID: 9886808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors.
    Liu M; Freedman LP
    Mol Endocrinol; 1994 Dec; 8(12):1593-604. PubMed ID: 7708050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of the interaction between Runx2 and VDR, two transcription factors involved in osteoblastogenesis.
    Marcellini S; Bruna C; Henríquez JP; Albistur M; Reyes AE; Barriga EH; Henríquez B; Montecino M
    BMC Evol Biol; 2010 Mar; 10():78. PubMed ID: 20236534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of 1,25-dihydroxyvitamin D3 receptor-mediated enhancement of osteocalcin gene transcription: effects of perturbing phosphorylation pathways by okadaic acid and staurosporine.
    Desai RK; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Endocrinology; 1995 Dec; 136(12):5685-93. PubMed ID: 7588324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.